GlycoMimetics (NASDAQ: GLYC) reported Q1 EPS of ($0.33), $0.05 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on GlycoMimetics (GLYC) click here.